CORCEPT THERAPEUTICS INC (CORT)

SEC filing

CORCEPT THERAPEUTICS INC

CORT · CIK 1088856

4 · Sep 3, 2026 · Chief Business Officer Robb Gary Charles was granted 328 shares at $56.69/share ($18,594); reported 91 shares

Chief Business Officer Robb Gary Charles was granted 328 shares at $56.69/share ($18,594); reported 91 shares

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).